Prospective Study of Dietary Phytoestrogen Intake and the Risk of Colorectal Cancer

Nutrition and Cancer

Volumn 68, Issue 3, 2016, Pages 388-395

  Hedelin, Maria ^a,b   Löf, Marie ^b,c   Sandin, Sven ^b   Adami, Hans Olov ^b,d   Weiderpass, Elisabete ^b,e,f,g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COUMESTROL; EQUOL; FLAVONOID; ISOFLAVONOID; LIGNAN DERIVATIVE; PHYTOESTROGEN; VITAMIN D;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CANCER RISK; CARBOHYDRATE INTAKE; COHORT ANALYSIS; COLORECTAL CANCER; DIETARY INTAKE; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NUTRIENT CONTENT; POPULATION RESEARCH; PROSPECTIVE STUDY; PROTEIN INTAKE; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; DIET; MIDDLE AGED; RISK FACTOR; SWEDEN;

ADULT; COHORT STUDIES; COLORECTAL NEOPLASMS; DIET; FEMALE; HUMANS; MIDDLE AGED; PHYTOESTROGENS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 84961392007     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1152380     Document Type: Article

References (47)

1. Adlercreutz H: Phyto-oestrogens and cancer. Lancet Oncol 3, 364-373, 2002.
2. Yan L and Spitznagel EL: Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117, 667-669, 2005.
3. Yan L, Spitznagel EL, and Bosland MC: Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19, 148-158, 2010.
4. Lofano K, Principi M, Scavo MP, Pricci M, Ierardi E, and Di Leo A: Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality? J Gastrointest Cancer 44, 1-11, 2013.
5. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263, 1998.
6. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, et al.: Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148, 4875-4886, 2007.
7. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, et al.: Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 25, 48-52, 2002.
8. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, et al.: Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39, 1251-1258, 2003
9. Wada-Hiraike O, Warner M, and Gustafsson JA. New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 34, 1114-1116, 2006.
10. Castiglione F, Taddei A, Rossi Degl'Innocenti D, Buccoliero AM, Bechi P, et al.: Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol 17, 231-236, 2008.
11. Jassam N, Bell SM, Speirs V, and Quirke P: Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 14, 17-21, 2005.
12. Xie LQ, Yu JP, and Luo HS: Expression of estrogen receptor beta in human colorectal cancer. World J Gastroenterol 10, 214-217, 2004.
13. Nanda K, Bastian LA, Hasselblad V, and Simel DL: Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93, 880-888, 1999.
14. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, and Allan JD: Postmenopausal hormone replacement therapy: scientific review. JAMA 288, 872-881, 2002.
15. Mueller SO, Simon S, Chae K, Metzler M, and Korach KS: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80, 14-25, 2004.
16. Adlercreutz H: Lignans and human health. Crit Rev Clin Lab Sci 44, 483-525, 2007.
17. Mazur W: Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12, 729-742, 1998.
18. Mazur W. Phytoestrogens: Occurrance in Foods, and Metabolism of Lignans in Man and Pigs. Helsinki: University of Helsinki, 2000. Available from: http://ethesis.hel sinki.fi/julkaisut/laa/kliin/vk/mazur/.
19. Johnsen NF, Olsen A, Thomsen BL, Christensen J, Egeberg R, et al.: Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women. Cancer Causes Control 21, 153-162, 2010.
20. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, et al.: Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136, 3046-3053, 2006.
21. Zamora-Ros R, Not C, Guino E, Lujan-Barroso L, Garcia RM, et al.: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish casecontrol study (the Bellvitge Colorectal Cancer Study). Cancer Causes Control 24, 549-557, 2013.
22. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 16, 684-693, 2007.
23. Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, et al.: Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 91, 440-448, 2010.
24. Lagiou P, Trichopoulos D, Sandin S, Lagiou A, Mucci L, et al.: Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr 96, 384-392, 2006.
25. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, et al.: Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138, 938-945, 2008.
26. Hedelin M, Lof M, Andersson TM, Adlercreutz H, and Weiderpass E: Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomark Prev 20, 308-317, 2011.
27. Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, et al.: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17, 169-180, 2006.
28. Milder IE, Arts IC, van de Putte B, Venema DP, and Hollman PC: Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93, 393-402, 2005.
29. Thompson LU, Boucher BA, Liu Z, Cotterchio M, and Kreiger N: Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54, 184-201, 2006.
30. Penalvo JL, Haajanen KM, Botting N, and Adlercreutz H: Quantification of lignans in food using isotope dilution gas chromatography/mass spectrometry. J Agric Food Chem 53, 9342-9347, 2005.
31. National Food Agency: Home page of the National Food Agency. Uppsala: National Food Agency. Available from: http://www.slv.se/default.aspx?idD231&epslanguageDENGB.
32. Willet W:Nutritional Epidemiology. 2nd ed. New York: Oxford University Press, 1998.
33. Ward HA and Kuhnle GG: Phytoestrogen consumption and association with breast, prostate and colorectal cancer in EPIC Norfolk. Arch Biochem Biophys 501, 170-175, 2010.
34. Kuijsten A, Arts IC, Hollman PC, van't Veer P, and Kampman E: Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomark Prev 15, 1132-1136, 2006.
35. Kuijsten A, Hollman PC, Boshuizen HC, Buijsman MN, van 't Veer P, et al.: Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study. Am J Epidemiol 167, 734-742, 2008.
36. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, et al.: Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study. Cancer Epidemiol Biomark Prev 17, 2891-2894, 2008.
37. Horn-Ross PL, Barnes S, Lee VS, Collins CN, Reynolds P, et al.: Reliability and validity of an assessment of usual phytoestrogen consumption (United States). Cancer Causes Control 17, 85-93, 2006.
38. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, et al.: Determinants of serum enterolactone concentration. Am J Clin Nutr 73, 1094-1100, 2001.
39. Johnsen NF, Hausner H, Olsen A, Tetens I, Christensen J, et al.: Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. J Nutr 134, 2691-2697, 2004.
40. Horner NK, Kristal AR, Prunty J, Skor HE, Potter JD, et al.: Dietary determinants of plasma enterolactone. Cancer Epidemiol Biomark Prev 11, 121-126, 2002.
41. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, et al.: Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 23, 37-45, 2012.
42. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, et al.: Comparison of risk factors for colon and rectal cancer. Int J Cancer 108, 433-442, 2004.
43. Iacopetta B: Are there two sides to colorectal cancer? Int J Cancer 101, 403-408, 2002.
44. Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, et al.: K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 24, 703-710, 2003.
45. Luchtenborg M, Weijenberg MP, Roemen GM, de Bruine AP, van den Brandt PA, et al.: APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis 25, 1219-1226, 2004.
46. Di Giuseppe D, Wallin A, Bottai M, Askling J, and Wolk A: Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis 73, 1949-1953, 2014.
47. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, et al.: Zinc and heme iron intakes and risk of colorectal cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr 96, 864-873, 2012.